Conditions: Type 2 Diabetes
Keywords: Type 2 Diabetes Inadequate Glycaemic Control Saxagliptin Metformin Sulfonylurea Triple Oral Therapy
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 257
Healthy volunteers: no

Brief summary:
The purpose of this study is to determine whether the addition of saxagliptin to a patient's combination treatment of metformin and sulfonylurea for a 24 week period will provide better control of the patient's type 2 diabetes and will be well tolerated.

Detailed description:
A 24-week, Multicentre, Randomised, Double-Blind, Placebo-Controlled Phase IIIb Study to Evaluate Efficacy and Safety of Saxagliptin in Combination with Metformin and Sulfonylurea in Subjects with Type 2 Diabetes who have Inadequate Glycaemic Control with Combination of Metformin and Sulfonylurea

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: Saxagliptin intervention 2: Placebo
Intervention descriptions: intervention 1: 5 mg tablet once daily for 24 weeks to be taken orally intervention 2: tablet once daily for 24 weeks to be taken orally

Protocol document: